Rabia Gurses Ozden's Net Worth

$1.32 Million

Estimate Recalculated Nov 1, 2024 09:19AM EST

Who is Rabia Gurses Ozden?

Rabia Gurses Ozden has an estimated net worth of $1.32 Million. This is based on reported shares across multiple companies, which include OCULAR THERAPEUTIX, INC, Adverum Biotechnologies, Inc., and Akouos, Inc..

SEC CIK

Rabia Gurses Ozden's CIK is 0001814883

Past Insider Trading and Trends

2022 was Rabia Gurses Ozden's most active year for acquiring shares with 5 total transactions. Rabia Gurses Ozden's most active month to acquire stocks was the month of June. 2023 was Rabia Gurses Ozden's most active year for disposing of shares, totalling 2 transactions. Rabia Gurses Ozden's most active month to dispose stocks was the month of December. 2024 saw Rabia Gurses Ozden paying a total of $30,841.56 for 357,979 shares, this is the most they've acquired in one year. In 2024 Rabia Gurses Ozden cashed out on 7,764 shares for a total of $38,431.80, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

OCULAR THERAPEUTIX, INC (OCUL) Snapshot price: $8.39

Chief Medical Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+78.67%
72.98K
$4.86
$30,841.56
153.05K
Feb 3 - Feb 5
Form 4
-7.72%
-7.76K
$4.95
-$38,431.80
92.77K
Jan 31
Form 4
-0.82%
-832.00
$4.93
-$4,101.76
100.53K
Jul 7
Form 4
-5.95%
-6.42K
$4.24
-$27,203.84
101.36K
Scheduled
Feb 6
Form 4
+106.38%
55.56K
—
—
107.78K
Jan 30
Form 4
+14.63%
6.67K
—
—
52.22K
Jul 1 - Jul 14
Form 3
—
0
—
—
0
No matching records found

Adverum Biotechnologies, Inc. (ADVM) Snapshot price: $6.76

Chief Medical Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 17
Form 4
—
0
—
—
0
Jun 9
Form 4
—
0
—
—
0
Mar 17
Form 3
—
0
—
—
0
No matching records found

Akouos, Inc. No price found

Chief Development Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found